Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors

Mise à jour : Il y a 4 ans
Référence : NCT00611494

Femme et Homme

  • | Pays :
  • Canada
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of the study is to assess the gastrointestinal tolerability of EC-MPS compared to MMF in maintenance transplant patients on a calcineurin inhibitor regimen, who require MMF dose reductions of 25% or more due to GI complications. The tested hypothesis is that the EC-MPS treatment is superior to the MMF therapy in terms of tolerability and that patients on the EC-MPS formulation will be able to tolerate higher doses compared to those on MMF.


Critère d'inclusion

  • Organ Transplantation

Liens